raloxifene hydrochloride has been researched along with Prostatic Hyperplasia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bjorling, DE; Keil, KP; Moses, MA; Nicholson, TM; Ricke, WA; Uchtmann, KS; Vezina, CM; Wood, RW | 1 |
| Chen, LF; Du, XL; Ma, HS; Ma, YX; Shi, JD; Yang, R; Yang, ZP; Zhang, J; Zhou, Y; Zhu, Y | 1 |
| Chung, LW; Neubauer, BL; Petrow, V; Sikes, RA; Thomsen, S | 1 |
3 other study(ies) available for raloxifene hydrochloride and Prostatic Hyperplasia
| Article | Year |
|---|---|
Estrogen receptor-α is a key mediator and therapeutic target for bladder complications of benign prostatic hyperplasia.
Topics: Animals; Estrogen Receptor alpha; Estrogen Receptor beta; Male; Mice; Mice, Inbred C57BL; Prostatic Hyperplasia; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Urinary Bladder Diseases | 2015 |
Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Aging; Animals; Cell Line; Cell Proliferation; Estrogen Antagonists; Finasteride; Humans; Male; Models, Animal; Proliferating Cell Nuclear Antigen; Prostate; Prostatic Hyperplasia; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Tamoxifen | 2010 |
Inhibition of experimentally induced mouse prostatic hyperplasia by castration or steroid antagonist administration.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Animals; Azasteroids; Dihydrotestosterone; DNA; Drug Therapy, Combination; Estrogen Antagonists; Female; Male; Mice; Mice, Inbred BALB C; Orchiectomy; Piperidines; Progesterone; Prostatic Hyperplasia; Raloxifene Hydrochloride; Urogenital System | 1990 |